Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Otitis Media - Overview
Otitis Media - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Otitis Media - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Otitis Media - Companies Involved in Therapeutics Development
Ceolia Pharma Co Ltd
Earno LLC
Furen Pharmaceutical Group Co Ltd
Hun Sanqing Pharmaceutical Co Ltd
Lee’s Pharmaceutical Holdings Ltd
Merck & Co Inc
MerLion Pharmaceuticals Pte Ltd
MyX Therapeutics Inc
Novus Therapeutics Inc
O-Ray Pharma Inc
Olymvax Biopharmaceuticals Inc
ProclaRx LLC
Vaxcyte Inc
Vyome Therapeutics Inc
Yuhan Corp
Otitis Media - Drug Profiles
(cholesteryl palmitate + colfosceril palmitate) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(dexamethasone + piperacillin + tazobactam) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
aspoxicillin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drug for Otitis Media - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drugs for Otitis Media - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Otitis Media - Dormant Projects
Otitis Media - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Otitis Media, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Otitis Media, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Otitis Media - Pipeline by Ceolia Pharma Co Ltd, H2 2020
Otitis Media - Pipeline by Earnano LLC, H2 2020
Otitis Media - Pipeline by Furen Pharmaceutical Group Co Ltd, H2 2020
Otitis Media - Pipeline by Hunan Sanqing Pharmaceutical Co Ltd, H2 2020
Otitis Media - Pipeline by Lee’s Pharmaceutical Holdings Ltd, H2 2020
Otitis Media - Pipeline by Merck & Co Inc, H2 2020
Otitis Media - Pipeline by MerLion Pharmaceuticals Pte Ltd, H2 2020
Otitis Media - Pipeline by MyX Therapeutics Inc, H2 2020
Otitis Media - Pipeline by Novus Therapeutics Inc, H2 2020
Otitis Media - Pipeline by O-Ray Pharma Inc, H2 2020
Otitis Media - Pipeline by Olymvax Biopharmaceuticals Inc, H2 2020
Otitis Media - Pipeline by ProclaRx LLC, H2 2020
Otitis Media - Pipeline by Vaxcyte Inc, H2 2020
Otitis Media - Pipeline by Vyome Therapeutics Inc, H2 2020
Otitis Media - Pipeline by Yuhan Corp, H2 2020
Otitis Media - Dormant Projects, H2 2020